LSC Webinars

  1. The Role Of Developability In Lead Candidate Selection 6/12/2025

    Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

  2. Optimizing The Progression Of Biotherapeutic Candidates To FIH Studies 6/9/2025

    Learn actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.

  3. A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles 6/3/2025

    A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.

  4. How To Optimize Labeling In A Pharmaceutical Environment 5/29/2025

    Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

  5. Accelerate And Enhance Biomanufacturing Operator Training 5/28/2025

    Unlock the power of blended operator training and learn how combining digital tools with hands-on instruction reduces errors, boosts retention, and empowers your workforce for real-world production success.

  6. Navigating Regulatory Shifts: EU GMP Annex 1 And USP 382 5/20/2025

    Strengthen risk mitigation strategies while ensuring regulatory alignment. Gain valuable insights into best practices and proactive approaches for building a robust and future-ready CCS.

  7. Mastering The Complexities Of Gene Therapy Document Writing 5/20/2025

    Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

  8. Optimizing Biotherapeutic Protein Expression With CHO Vector Technology 5/19/2025

    Review the development of a high-strength synthetic gene promoter that enhances titers while maintaining exceptional product quality and expression stability, to support more efficient biomanufacturing.

  9. Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation 5/15/2025

    Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

  10. Digital Transformation In Contract Manufacturing: A Leadership Perspective 5/13/2025

    Discover how PCI Pharma Services embraced digital transformation and gain expert insight on overcoming challenges, driving innovation, and maintaining core values in a regulated industry.